Abstract
Brain-derived extracellular vesicles (EVs) play an active role in Alzheimer's disease (AD), relaying important physiological information about their host tissues. The internal cargo of EVs is protected from degradation, making EVs attractive AD biomarkers. However, it is unclear how circulating EVs relate to EVs isolated from disease-vulnerable brain regions. We developed a novel method for collecting EVs from the hippocampal interstitial fluid (ISF) of live mice. EVs (EVISF) were isolated via ultracentrifugation and characterized by nanoparticle tracking analysis, immunogold labelling, and flow cytometry. Mass spectrometry and proteomic analyses were performed on EVISF cargo. EVISF were 40–150 nm in size and expressed CD63, CD9, and CD81. Using a model of cerebral amyloidosis (e.g., APPswe, PSEN1dE9 mice), we found protein concentration increased but protein diversity decreased with Aβ deposition. Genotype, age, and Aβ deposition modulated proteostasis- and immunometabolic-related pathways. Changes in the microglial EVISF proteome were sexually dimorphic and associated with a differential response of plaque associated microglia. We found that female APP/PS1 mice have more amyloid plaques, less plaque associated microglia, and a less robust- and diverse- EVISF microglial proteome. Thus, in vivo microdialysis is a novel technique for collecting EVISF and offers a unique opportunity to explore the role of EVs in AD.
Original language | English |
---|---|
Article number | 12398 |
Journal | Journal of Extracellular Vesicles |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals LLC on behalf of International Society for Extracellular Vesicles.
Funding
We would like to thank Dr. David Holtzman for the generous gifts of Aβ antibodies. We would like to acknowledge the following grants: Wake Forest Alzheimer's Disease Research Center pilot and R01AG061805 (G.D., S.L.M.), P30AG072947 (S.L.M.), K01AG050719 (S.L.M.), R01AG068330 (S.L.M.), BrightFocus Foundation A20201775S (S.L.M.), Averill Foundation (S.L.M.), F31AG071119 (M.P.), and Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource, supported by the National Cancer Institute's Cancer Center Support Grant award number P30CA012197.
Funders | Funder number |
---|---|
Averill Foundation | F31AG071119 |
BrightFocus Foundation A20201775S | |
National Cancer Institute's Cancer Center | P30CA012197 |
Comprehensive Cancer Center at Wake Forest Baptist Medical Center |
Keywords
- APP/PS1
- amyloid-β
- exosomes
- extracellular vesicles (EVs)
- interstitial fluid
- microglia
- plaques
- sex differences
ASJC Scopus subject areas
- Histology
- Cell Biology